Aurobindo Pharma launches Adquey in US dermatology market
Aurobindo Pharma's subsidiary Acrotech Biopharma has launched Adquey (difamilast 1%), a non-steroidal topical ointment for mild-to-moderate atopic dermatitis, in the US. The drug, licensed from Japan's Otsuka Pharmaceutical, is approved for adults…
